Login / Signup

Reimagining diversity in multiple myeloma clinical trials.

Dany HabrMassimo Corsaro
Published in: Hematological oncology (2022)
Keyphrases
  • multiple myeloma
  • clinical trial
  • phase ii
  • open label
  • phase iii
  • study protocol
  • randomized controlled trial